- Home
- INZY vs CHMG Comparison
INZY vs CHMG Comparison
Compare INZY & CHMG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INZY
- CHMG
- Stock Information
- Founded
- INZY 2015
- CHMG 1833
- Country
- INZY United States
- CHMG United States
- Employees
- INZY N/A
- CHMG N/A
- Industry
- INZY Biotechnology: Pharmaceutical Preparations
- CHMG Major Banks
- Sector
- INZY Health Care
- CHMG Finance
- Exchange
- INZY Nasdaq
- CHMG Nasdaq
- Market Cap
- INZY 256.3M
- CHMG 224.0M
- IPO Year
- INZY 2020
- CHMG N/A
- Fundamental
- Price
- INZY N/A
- CHMG $50.15
- Analyst Decision
- INZY Buy
- CHMG Hold
- Analyst Count
- INZY 9
- CHMG 3
- Target Price
- INZY $15.22
- CHMG $55.00
- AVG Volume (30 Days)
- INZY 989.2K
- CHMG 13.9K
- Earning Date
- INZY 08-05-2025
- CHMG 07-17-2025
- Dividend Yield
- INZY N/A
- CHMG 2.54%
- EPS Growth
- INZY N/A
- CHMG N/A
- EPS
- INZY N/A
- CHMG 4.74
- Revenue
- INZY N/A
- CHMG $96,163,000.00
- Revenue This Year
- INZY N/A
- CHMG $11.98
- Revenue Next Year
- INZY N/A
- CHMG $8.47
- P/E Ratio
- INZY N/A
- CHMG $10.64
- Revenue Growth
- INZY N/A
- CHMG 0.44
- 52 Week Low
- INZY $0.72
- CHMG $40.71
- 52 Week High
- INZY $6.24
- CHMG $55.73
- Technical
- Relative Strength Index (RSI)
- INZY 82.67
- CHMG 63.83
- Support Level
- INZY $3.94
- CHMG $48.37
- Resistance Level
- INZY $3.97
- CHMG $50.05
- Average True Range (ATR)
- INZY 0.01
- CHMG 1.83
- MACD
- INZY -0.08
- CHMG 0.27
- Stochastic Oscillator
- INZY 100.00
- CHMG 99.27
About INZY Inozyme Pharma Inc.
Inozyme Pharma Inc is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of diseases impacting bone health and blood vessel function. The company is focused on developing a novel therapy to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies. Its product candidate, INZ-701, is a soluble, recombinant, genetically engineered fusion protein that is designed to correct a defect in a pathway involving ENPP1 and ABCC6 deficiencies.
About CHMG Chemung Financial Corp
Chemung Financial Corp is a bank holding firm. Through its subsidiaries, the company provides various financial services, including demand, savings, and time deposits, commercial, residential, and consumer loans, letters of credit, wealth management services, employee benefit plans, insurance products, mutual funds, and brokerage services, among others. The company's reportable segments are Core Banking, Wealth Management (WMG) services, and Holding company and CFS. Maximum revenue is generated from the Core Banking segment, which derives revenue by attracting deposits from the general public and using such funds to originate different types of loans, and to invest in securities. The Wealth Management (WMG) services segment provides trust and investment advisory services to clients.